Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: June 19, 2017
Context: The filing announces the scheduling of the Company's Annual General Meeting of Shareholders to be held on July 25, 2017, at 12:00 p.m. Israel time at its offices in Petach Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice regarding shareholder meeting logistics and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates versus prior periods are disclosed in this filing. The document focuses exclusively on corporate governance procedures for the upcoming shareholder meeting.
Guidance, Outlook, and Management Commentary
Shareholder Meeting Details:
- Date: July 25, 2017
- Time: 12:00 p.m. (Israel time)
- Location: Company offices, Petach Tikva, Israel
- Notice and Proxy Statement (Exhibit 99.1) detailing proposals and voting procedures.
- Proxy Card for ordinary share holders (Exhibit 99.2).
- Voting Instruction Card for American Depositary Share holders (Exhibit 99.3).
Key Facts for Investor Verification
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the deadline for submitting proxy cards or voting instruction cards to ensure participation in the July 25, 2017 meeting.
- Note that this filing incorporates by reference into Registration Statements on Form F-3 (File Nos. 333-195124, 333-199033, 333-204795, and 333-209037).
- Recognize that no financial performance data is contained within this specific Form 6-K.